Bionik Laboratories Corp. (BNKL)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD

Add to watchlist

0.0000

-0.1000

(-100.00%)

As of 10:33AM EDT. Market open.

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	0	0
Sales	N/A	0
Net shares purchased (sold)	0	0
Total insider shares held	10.07M	N/A
% net shares purchased (sold)	N/A	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.60 per share.	Indirect	1,861,727	13 Jun 2023	3,102,878
AUBERTON-HERVE ANDRE-JACQUES Director	Conversion of Exercise of derivative security at price 0.60 per share.	Indirect	111,667	13 Jun 2023	186,111
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 0.60 per share.	Indirect	108,333	09 Jun 2023	180,555
AUBERTON-HERVE ANDRE-JACQUES Director	Purchase at price 0.60 per share.	Indirect	390,000	09 Jun 2023	650,000
MATINE CHARLES Director	Purchase at price 0.60 per share.	Direct	108,333	09 Jun 2023	180,555
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 9.50 per share.	Indirect	739,926	31 Mar 2022	77,887
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 3.16 - 3.59 per share.	Indirect	431,954	15 Jul 2021	120,759
AUBERTON-HERVE ANDRE-JACQUES Director	Conversion of Exercise of derivative security at price 3.16 - 3.59 per share.	Indirect	210,201	15 Jul 2021	59,378
MARTIN JOSEPH R Director	Purchase at price 2.50 per share.	Direct	66,075	29 Mar 2021	26,430
MALONE PETER GERALD Director	Purchase at price 2.50 per share.	Direct	66,075	29 Mar 2021	26,430
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Stock Award(Grant) at price 0.00 per share.	Indirect	0	29 Mar 2021	61,256
MATINE CHARLES Director	Purchase at price 2.50 per share.	Direct	66,075	29 Mar 2021	26,430
THEVENON AUDREY Director	Purchase at price 2.50 per share.	Direct	66,075	29 Mar 2021	26,430
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 2.50 per share.	Indirect	338,900	26 Mar 2021	135,560
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security		Indirect		25 Nov 2019	4,997
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 6.80 per share.	Indirect	518,330	30 Sept 2019	76,225
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 3.76 per share.	Indirect	399,906	26 Aug 2019	106,358
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 3.89 per share.	Indirect	766,747	28 Mar 2019	197,234
AUBERTON-HERVE ANDRE-JACQUES Chairman of the Board	Conversion of Exercise of derivative security at price 3.89 per share.	Indirect	316,800	28 Mar 2019	81,492
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.05 per share.	Indirect	2,229,936	24 Jul 2018	43,468,547
AUBERTON-HERVE ANDRE-JACQUES Chairman of the Board	Conversion of Exercise of derivative security at price 0.05 per share.	Indirect	343,119	24 Jul 2018	6,688,480
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.06 per share.	Indirect	983,796	13 Jun 2018	15,740,728
AUBERTON-HERVE ANDRE-JACQUES Director	Conversion of Exercise of derivative security at price 0.06 per share.	Indirect	129,954	13 Jun 2018	2,079,267
GASTON-DREYFUS REMI Director and Beneficial Owner of more than 10% of a Class of Security	Conversion of Exercise of derivative security at price 0.06 per share.	Indirect	4,716,462	30 Mar 2018	75,463,389
AUBERTON-HERVE ANDRE-JACQUES Director	Conversion of Exercise of derivative security at price 0.06 per share.	Indirect	792,465	30 Mar 2018	12,679,436

NZD/USD0.6077-0.0016(-0.27%)

ALL ORDS7,992.30-21.50(-0.27%)

OIL83.15+1.61(+1.97%)

GOLD2,337.60-2.00(-0.09%)

Bionik Laboratories Corp. (BNKL)

Insider transactions

Insider transactions reported - last two years

NZD/USD
0.6077
-0.0016(-0.27%)

ALL ORDS
7,992.30
-21.50(-0.27%)

OIL
83.15
+1.61(+1.97%)

GOLD
2,337.60
-2.00(-0.09%)